MSD Commited to bringing out the best in medicine
Contact UsWorldwide
   
Email Updates
Request More Information

 

Links

This Internet site provides links or references to other sites. 
Merck does not review or control the content of any non-Merck site.  Merck does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-Merck sources.  Any links to other sites are provided merely as a convenience to the users of this Internet site, and use of those sites is subject to the conditions of use set forth therein.

LATEST ARTICLES
CASIOPEA
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma
View article 
COMPACT
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
View article
ASSOCIATIONS

World Health Organization: Asthma
http://www.who.int/health_topics/asthma/en/

American Academy of Allergy Asthma & Immunology
http://www.aaaai.org/

The National Asthma Council Australia (NAC)
http://www.nationalasthma.org.au/

American Thoracic Society (ATS)
http://www.thoracic.org/

European Academy of Allergology and Clinical Immunology (EAACI)
http://www.congrex.com/eaaci2003/

European Respiratory Society (ERS)
http://www.ersnet.org/

JOURNALS
CHEST: The Cardiopulmonary and Critical Care Journal
http://www.chestjournal.org/

European Respiratory Journal and European Respiratory Review
http://www.personal.u-net.com/~ersj/

Thorax Online - The Journal of the British Thoracic Society
 http://thorax.bmjjournals.com/

PrintPrint
SINGULAIR (montelukast sodium) is a registered trademark of Merck & Co., Inc., Whitehouse Station, NJ, USA.
Copyright © 2004 Merck & Co., Inc., All rights reserved.
Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA) Disclaimer